Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 233
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05505994 | The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin | ||
| NCT04294251 | Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy | ||
| NCT02693522 | Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency | ||
| NCT05465668 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C | ||
| NCT05886933 | Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet | ||
| NCT01094847 | Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine | ||
| NCT03369990 | DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy | ||
| NCT05660135 | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia | ||
| NCT05500898 | Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults | ||
| NCT06671392 | A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension | ||
| NCT06647888 | Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia | ||
| NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
| NCT06866509 | To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients | ||
| NCT06592495 | Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 | ||
| NCT05816681 | Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea. | ||
| NCT01764295 | Clinical Study for Patients With Hypertension Associated With Dyslipidemia | ||
| NCT02089399 | Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers | ||
| NCT04541485 | To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) | ||
| NCT03947528 | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions | ||
| NCT02568150 | Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines | ||
| NCT05889143 | A Study to Evaluate the Efficacy and Safety of CREZET Tablet | ||
| NCT01552954 | Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan | ||
| NCT07533266 | Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer | ||
| NCT05797922 | To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers | ||
| NCT04159961 | Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers | ||
| NCT05109702 | A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye | ||
| NCT03573622 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions | ||
| NCT06036342 | Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination | ||
| NCT03005223 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers | ||
| NCT06427083 | Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus | ||
| NCT06354127 | DWP450 for Treating Moderate to Severe Glabellar Lines | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT05747664 | To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function | ||
| NCT02385032 | Comparative Bioavailability Study of UDCA | ||
| NCT06736587 | Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers | ||
| NCT04003441 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers | ||
| NCT03574285 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions | ||
| NCT03184402 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT05868967 | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | ||
| NCT05376930 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. | ||
| NCT04749173 | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. | ||
| NCT07190391 | Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis | ||
| NCT03753477 | Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 | ||
| NCT06025409 | Evaluate the Efficacy and Safety of DWJ108J | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT04341454 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis | ||
| NCT03811080 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease | ||
| NCT04784910 | Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer | ||
| NCT02622685 | A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects |
